# Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer

> **NCT00004901** · PHASE1,PHASE2 · COMPLETED · sponsor: **Robert H. Lurie Cancer Center**

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** ethynyluracil
- **DRUG:** fluorouracil
- **DRUG:** hydroxyurea
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00004901
- **Lead sponsor:** Robert H. Lurie Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** —
- **Final completion:** 2004-07
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004901, "Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*